Nonsmall Cell Lung Cancer Clinical Trial
Official title:
A Feasibility Study of Genomically Guided Radiation Dose Personalization in the Management of Locally Advanced Non-Small Cell Lung Cancer
The purpose of the study is to determine the feasibility of genomically guided radiation therapy (RT) with concurrent chemotherapy in the management of stage II and III non-small cell lung cancer (NSCLC).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06147570 -
A Study of HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
|
Phase 2 | |
Recruiting |
NCT01312337 -
Iressa for EGFR Mutation Negative Non-small Cell Lung Cancer (NSCLC)
|
Phase 2 | |
Completed |
NCT05860582 -
A Study of [14C]GB491 in Male Healthy Subjects
|
Phase 1 | |
Terminated |
NCT02669914 -
MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors
|
Phase 2 | |
Completed |
NCT02562027 -
SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer
|
N/A | |
Recruiting |
NCT05358249 -
Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT02954523 -
Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations
|
Phase 1/Phase 2 | |
Terminated |
NCT03998189 -
Metabolic and Microbial Profiling of Lung Cancer
|
N/A | |
Not yet recruiting |
NCT03258671 -
IMRT and Timing in Combination With EGFRTKI for Stage IV Non-small-cell Lung Cancer
|
N/A | |
Recruiting |
NCT03838588 -
The Tracking Molecular Evolution for NSCLC (T-MENC) Study
|
||
Active, not recruiting |
NCT04984811 -
NT-I7 in Combination With Atezolizumab in Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLC
|
Phase 2 | |
Recruiting |
NCT05688280 -
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS
|
Phase 1/Phase 2 | |
Recruiting |
NCT02951611 -
Effects of Acupuncture Stimulation on Systemic Inflammation
|
N/A | |
Recruiting |
NCT02974933 -
Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer
|
Phase 2 | |
Active, not recruiting |
NCT02980536 -
cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia China
|
||
Completed |
NCT02972216 -
Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy
|
Phase 4 | |
Recruiting |
NCT02905591 -
A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC
|
Phase 2 | |
Active, not recruiting |
NCT02981108 -
A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLC
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT02299141 -
Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer
|
Phase 2 | |
Recruiting |
NCT04900935 -
Patient-centered, Optimal Integration of Survivorship and Palliative Care
|
N/A |